Methylene Blue Analogues with Marginal Monoamine Oxidase Inhibition Retain Antidepressant-like Activity (2018)

Peer-Reviewed Study · Delport A, Harvey BH, Petzer A, Petzer JP. · July 25, 2018

Delport A et al., 2018-07-25: Rat forced-swim study of five new methylene blue analogues: all were antidepressant-like while being 7- to 70-fold weaker MAO-A inhibitors than methylene blue, leading the authors to conclude that mechanisms other than MAO-A inhibition underlie the antidepressant-like effect.

we posit that other MB-related mechanisms may underlie their antidepressant effects

Delport A et al., 2018-07-25: Rat forced-swim study of five new methylene blue analogues: all were antidepressant-like while being 7- to 70-fold weaker MAO-A inhibitors than methylene blue, leading the authors to conclude that mechanisms other than MAO-A inhibition underlie the antidepressant-like effect. Study type: animal (acute forced swim test in rats). N: not stated in abstract (five analogues, comparison with imipramine and MB). Country: South Africa (North-West University). Dose: MB IC50 for MAO-A 0.07 microM; analogues 0.518-4.73 microM; behavioural doses not in abstract. Comparator: imipramine and methylene blue. Funder/conflicts not stated in abstract. Relevance to C8: directly undercuts a monoamine-oxidation-based causal explanation, and by extension the idea that antidepressant action depends on raising serotonin/dopamine. Study type: animal.